Source: Annual Congress 2003 - Severe pulmonary infection and sepsis
Disease area: Pulmonary vascular diseases, Respiratory critical care



Rating:

Share or cite this content

Citations should be made in the following way:
H. Spapen, D. N. Nguyen, J. Troubleyn, B. Scott, L. Huyghens (Brussels, Belgium). Cardiovascular effects of high dose N-acetylcysteine in severe pneumonia-induced sepsis. Eur Respir J 2003; 22: Suppl. 45, 2871

Member's Comments

No comment yet.

Related content which might interest you: The effect of mercaptoethylguanidine on acute lung injury associated with sepsis Source: Eur Respir J 2003; 22: Suppl. 45, 451s Year: 2003 N-acetylcysteine and dexamethasone in the prevention of respiratory complications in acute pancreatitis Source: Eur Respir J 2007; 30: Suppl. 51, 51s Year: 2007 Salmeterol prevents pneumonia and reduces biomarkers of inflammation/epithelial damage but not acute lung injury following oesophagectomy-the results of BALTI-prevention trial Source: Annual Congress 2013 –Acute lung injury: novel clinical and experimental insights Year: 2013 Impact of macrolide therapy on mortality in severe sepsis caused by pneumonia Source: Eur Respir J 2009; 33: 521 Year: 2009 Efficacy of surfactant-BL in treatment ARDS in patients with severe inhalation injury Source: Eur Respir J 2006; 28: Suppl. 50, 345s Year: 2006 The effect of roflumilast on lipopolysaccharide-induced acute lung injury during neutropenia recovery in mice Source: Virtual Congress 2021 – Developments in biomarkers and treatment strategies for chronic lung diseases Year: 2021 Effects of high dose N-acetylcysteine in COPD patients Source: Annual Congress 2012 - Trials in COPD: novel treatments and insights Year: 2012 Effect of 2-Year therapy with Roflumilast in severe systemic inflammation in COPD with metabolic syndrome Source: International Congress 2019 – Advances in COPD pharmacology Year: 2019 Therapeutic effect of hypothermia on endotoxin-induced acute lung injury in rats Source: Eur Respir J 2004; 24: Suppl. 48, 265s Year: 2004 Risk of myocardial infarction and cardiovascular death associated with inhaled corticosteroids in COPD Source: Eur Respir J 2010; 35: 1003-1021 Year: 2010 The effect of long-term treatment with erdosteine on moderate or severe COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 292s Year: 2005 Early administrations of dexamethasone, n-acetylcysteine and aprotinin have beneficial effects on inflammatory and oxidant-antioxidant status after lung contusion in rats Source: Annual Congress 2008 - Inflammatory trigger mechanisms in asthma and COPD Year: 2008 Dose dependent increased mortality risk in COPD patients treated with oral glucocorticoids Source: Eur Respir J 2001; 17: 337-342 Year: 2001 Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: A randomized clinical trial Source: International Congress 2015 – Acute critical care: news from the ICU Year: 2015 Cardiovascular safety of high doses of the nebulized bronchodilators in acute severe asthma Source: Eur Respir J 2004; 24: Suppl. 48, 541s Year: 2004 Effect of erdosteine in moderately severe COPD patients Source: International Congress 2018 – Pharmacological management of COPD Year: 2018 Creatine supplementation attenuates systemic and pulmonary effects of acute lung injury induced by pulmonary ischemia-reperfusion in rats Source: Annual Congress 2012 - Lung transplantation: studies in candidates and recipients Year: 2012 Comparison of reducing effect on lung injury of dexamethasone and bosentan in acute lung injury: An experimental study Source: International Congress 2014 – Experimental models in acute lung injury Year: 2014 Aspirin reduces acute lung injury in rats subjected to severe hemorrhage Source: Eur Respir J 2004; 24: Suppl. 48, 265s Year: 2004